Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the recipient of a large decline in short interest in October. As of October 30th, there was short interest totaling 7 shares, a decline of 99.7% from the October 15th total of 2,190 shares. Based on an average daily trading volume, of 12,811 shares, the days-to-cover ratio is presently 0.0 days.
Biofrontera Price Performance
NASDAQ:BFRIW remained flat at $0.00 on Tuesday. The business has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.03. Biofrontera has a 52-week low of $0.00 and a 52-week high of $0.15.
Biofrontera Company Profile
Biofrontera Inc. is a biopharmaceutical company focused on dermatology. It develops and commercializes treatments for sun-damaged skin and other conditions, with an emphasis on photodynamic therapy, which uses a light-sensitive medicine activated by a light source. Biofrontera Inc. became a separately traded U.S. company after its separation from Germany-based Biofrontera AG. BFRIW represents warrants associated with Biofrontera Inc., rather than the company’s common stock.
Featured Stories
- Five stocks we like better than Biofrontera
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
